Yu Yao

6.0k total citations
112 papers, 3.0k citations indexed

About

Yu Yao is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Yu Yao has authored 112 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Genetics, 44 papers in Molecular Biology and 34 papers in Oncology. Recurrent topics in Yu Yao's work include Glioma Diagnosis and Treatment (47 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Immunotherapy and Immune Responses (16 papers). Yu Yao is often cited by papers focused on Glioma Diagnosis and Treatment (47 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Immunotherapy and Immune Responses (16 papers). Yu Yao collaborates with scholars based in China, United States and Hong Kong. Yu Yao's co-authors include Ying Mao, Liangfu Zhou, Ho‐Keung Ng, Lingchao Chen, Aden Ka‐Yin Chan, Wei Hua, Zengxin Qi, Zhiyong Qin, Zhenyu Zhang and Hongzhi Xu and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Nature Genetics.

In The Last Decade

Yu Yao

104 papers receiving 3.0k citations

Peers

Yu Yao

GENET

ONCOL

IMMUN

Juan Manuel Sepúlveda-Sánchez Spain

Jason T. Huse United States

Shouwei Li China

Solmaz Sahebjam United States

Logan A. Walsh Canada

Jennifer S. Yu United States

Véronique Quillien France

Benoît Lhermitte France

Joy Gumin United States

S. Andrew United States

Juan Manuel Sepúlveda-Sánchez Spain

Yu Yao

1.7k ×1.5

GENET

1.2k ×1.1

1.5k ×1.7

ONCOL

637 ×0.8

844 ×1.3

IMMUN

Citations per year, relative to Yu Yao Yu Yao (= 1×) peers Juan Manuel Sepúlveda-Sánchez

Countries citing papers authored by Yu Yao

Since Specialization

Citations

This map shows the geographic impact of Yu Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Yao more than expected).

Fields of papers citing papers by Yu Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Yao. The network helps show where Yu Yao may publish in the future.

Co-authorship network of co-authors of Yu Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Yao. A scholar is included among the top collaborators of Yu Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Yao. Yu Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yao, Yu, Si Shi, Yaowu He, et al.. (2024). Combination of arsenic trioxide and apatinib synergistically inhibits small cell lung cancer by down-regulating VEGFR2/mTOR and Akt/c-Myc signaling pathway via GRB10. Hereditas. 161(1). 29–29.

Yao, Yu, et al.. (2024). METTL14-mediated m6A modification enhances USP22-ERα axis to drive breast cancer malignancy. Pharmacological Research. 210. 107509–107509. 4 indexed citations

Zhang, Jinsen, Rui Sun, Ying Liu, et al.. (2024). Proteomic profiling of gliomas unveils immune and metabolism-driven subtypes with implications for anti-nucleotide metabolism therapy. Nature Communications. 15(1). 10005–10005. 10 indexed citations

Qi, Ying, et al.. (2024). B7-H4 reduces the infiltration of CD8+T cells and induces their anti-tumor dysfunction in gliomas. Neoplasia. 54. 101007–101007. 3 indexed citations

Meng, Chi, et al.. (2022). A random forest-based metabolic risk model to assess the prognosis and metabolism-related drug targets in ovarian cancer. Computers in Biology and Medicine. 153. 106432–106432. 23 indexed citations

Qi, Ying, Di Chen, Qiqi Lu, Yu Yao, & Chunxia Ji. (2019). Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma. Disease Markers. 2019. 1–14. 29 indexed citations

Ren, Changhong, Yu Yao, Rongrong Han, et al.. (2018). Cerebral ischemia induces angiogenesis in the peri-infarct regions via Notch1 signaling activation. Experimental Neurology. 304. 30–40. 40 indexed citations

Chan, Aden Ka‐Yin, Zhifeng Shi, Yanxi Li, et al.. (2017). Adult IDH wild-type lower-grade gliomas should be further stratified. Neuro-Oncology. 19(10). 1327–1337. 160 indexed citations

Yao, Yu, Hongxing Ye, Zengxin Qi, et al.. (2016). B7-H4(B7x)–Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients. Clinical Cancer Research. 22(11). 2778–2790. 148 indexed citations

10.

Xu, Ming, et al.. (2016). Extensive Therapies for Extraneural Metastases from Glioblastoma, as Confirmed with the OncoScan Assay. World Neurosurgery. 90. 698.e7–698.e11. 16 indexed citations

11.

Tang, Chao, Jun Guo, Hong Chen, et al.. (2015). Gene mutation profiling of primary glioblastoma through multiple tumor biopsy guided by 1H-magnetic resonance spectroscopy.. PubMed Central. 8(5). 5327–35. 27 indexed citations

12.

Chen, Lingchao, Hongxing Ye, Xiaomei Wang, et al.. (2014). Evidence of brain tumor stem progenitor-like cells with low proliferative capacity in human benign pituitary adenoma. Cancer Letters. 349(1). 61–66. 27 indexed citations

13.

Yue, Qi, Xin Zhang, Hongxing Ye, et al.. (2013). The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma. Journal of Neuro-Oncology. 116(2). 251–259. 61 indexed citations

14.

Chen, Lingchao, Haiyan Zhang, Zhiyong Qin, et al.. (2013). Serological Identification of URGCP as a Potential Biomarker for Glioma. CNS Neuroscience & Therapeutics. 20(4). 301–307. 12 indexed citations

15.

Wu, Zhe, Lin Cai, Shao Jian Lin, et al.. (2013). High-mobility group box 2 is associated with prognosis of glioblastoma by promoting cell viability, invasion, and chemotherapeutic resistance. Neuro-Oncology. 15(9). 1264–1275. 41 indexed citations

16.

Wang, Yang, Li Pan, Ying Mao, et al.. (2012). Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients. European journal of medical research. 17(1). 25–25. 52 indexed citations

17.

Wang, Xiang, Yu Yao, Jinhui Wang, et al.. (2012). Newly diagnosed acute lymphoblastic leukemia in China (II): prognosis related to genetic abnormalities in a series of 1091 cases. Leukemia. 26(7). 1507–1516. 48 indexed citations

18.

Hua, Wei, Yu Yao, Liangfu Zhou, et al.. (2009). Stem-like cells associated antigens augment the effect of dendritic cells-based vaccination against human malignant glioma cells in vitro. Zhonghua shenjing waike zazhi. 25(9). 850–854. 1 indexed citations

19.

Yao, Yu, et al.. (2009). Brain tumor stem cells: view from cell proliferation. Surgical Neurology. 71(3). 274–279. 6 indexed citations

20.

Wang, Zheng, Jia Fan, Jian Zhou, et al.. (2008). Preventive chemotherapy for hepatocellular carcinoma exceeding Milan criteria after fiver transplantation. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 7(4). 268–270. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact